Gadolinium-centered contrast agents (GBCAs) are extensively used in magnetic resonance imaging (MRI) to improve the visibility of blood vessels, tumors, inflammation, as well as other interior constructions. Whilst generally thought of Risk-free, issues about GBCA toxicity have emerged in the last two decades—significantly in sufferers with impai